Tangen Biosciences

Recent Finacing

Series B

Recent Raise

$12.2M

Tangen Biosciences develops the TangenDx rotary isothermal nucleic acid detection platform and GeneSpark instrument for point-of-care molecular diagnostics detecting respiratory, bacterial, and fungal pathogens from clinical specimens.

Founded 2013

Connecticut, United States

1-10

Private

tangenbio.com

Highlights

Focus Areas

Biotechnology

Health Care

Health Diagnostics

Medical

Medical Device

Recent Investors

A

Financials

$21.2M

Total Raised

2

Funding rounds

5

Investors

Team

Upgrade to view the team

See the team members at Tangen Biosciences.